Exhausting Multiple Hemodialysis Access Failures
Open Access
- 1 January 2014
- journal article
- case report
- Published by ScopeMed in Medical Archives
- Vol. 68 (5) , 361-363
Abstract
Vascular access is often considered the Achilles heel the of hemodialysis because of its impact on morbidity, all cause mortality and finally costs of these patients. The most common complication of permanent hemodialysis (HD) vascular access is thrombosis, with some cases being related to hypercoagulability states. Antiphospholipid antibody syndrome (APAS) is a cause of increased thrombotic tendency, and this may complicate the management of such patients on HD. We describe a 41-year-old woman with end stage renal disease (ESRD) from Adult Polycystic Kidney Disease who was referred to our tertiary care center for treatment and selection of renal replacement therapy form. It was thought to initiate with peritoneal dialysis considering her actual conditions. She was putted on hemodialysis for several sessions, and a subclavian cathether was her first vascular access. The surgeon created an arterio-venous fistula which did not mature. After the implantation of the peritoneal cathether she started peritoneal dialysis and continued living with that for 2 years. She felt exhausted and because of a grave peritonitis episode accompanied with procedure failure and a long hospitalization she was transferred to hemodialysis. Renal transplantation was not possible because she didn't have a kidney donation. She was maintained on regular HD, but her dialysis care was complicated by recurrent vascular access failures. She had multiple interventions for arterio-venous fistulas and grafts but almost all of them failed due to thrombosis to the extent that only one access site was available for her routine renal replacement treatment. A thorough thrombophilia screen confirmed the presence of antiphospholipid antibodies. A diagnosis of APAS was made and she was anticoagulated with warfarin. The AVG made in this last available site is still working from 18 months. If it fails we have no answers and solutions for her. The presence of APAS can complicate HD management by causing recurrent vascular access thrombosis and failure, and nephrologist must remain alert to this possibility. Checking and treating as soon as possible it's our future challenge.Keywords
This publication has 11 references indexed in Scilit:
- Thrombophilia and the Risk for Hemodialysis Vascular Access ThrombosisJournal of the American Society of Nephrology, 2005
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsArthritis & Rheumatism, 2002
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- The Intrarenal Vascular Lesions Associated with Primary Antiphospholipid SyndromeJournal of the American Society of Nephrology, 1999
- Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosisKidney International, 1995
- Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosisAmerican Journal of Kidney Diseases, 1995
- The Management of Thrombosis in the Antiphospholipid-Antibody SyndromeNew England Journal of Medicine, 1995
- Permanent Vascular Access: A Nephrologist's ViewAmerican Journal of Kidney Diseases, 1993
- Renal involvement in primary antiphospholipid syndrome.1992
- Anticardiolipin Antibodies and Lupus Anticoagulant in End-Stage Renal DiseaseNephrology Dialysis Transplantation, 1991